| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 1159.0 | 1121.1 | 931.3 |
| Other income | 36.7 | 21.7 | 22.9 |
| Total income | 1195.8 | 1142.8 | 954.2 |
| Profit before exceptional items & tax | 187.3 | 156.4 | 183.3 |
| Exceptional items | 0.0 | -36.6 | -49.9 |
| Profit before tax | 187.3 | 119.8 | 133.4 |
| Net profit | 141.7 | 95.0 | 101.4 |
| Operating margin | 15.7% | 10.5% | 14.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +39.70% |
|---|---|
| Net profit, quarter on quarter | +49.20% |
| Revenue, year on year | +24.40% |
BSE results filing, NSE: MEDANTA. Figures extracted from the filing.
Global Health Ltd: key numbers
- Share price
- ₹1,293.80
- Market cap
- ₹34,787 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 62.5×Sector 53.1×
- Promoter holding
- 33.00%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Employee Stock Options
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
- Value
- ₹0.45 Cr
Global Health Annual General Meeting
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Other Announcement
Global Health Limited has filed its Business Responsibility and Sustainability Report for the financial year 2025-26 as mandated by SEBI (LODR) regulations.
Global Health Annual General Meeting
Global Health Limited has announced its 22nd Annual General Meeting to be held on September 16, 2026, to consider financial statements, dividends, and director re-appointment.
- Value
- ₹0.12 Cr
Global Health Annual Report
Global Health Limited has submitted its Annual Report for the financial year 2025-26, alongside the notice for its 22nd Annual General Meeting.